We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
A few cases of liver cancers showed strong membranous positivity. Weak to moderate staining was observed in several renal, endometrial and prostate cancers. Remaining cancers were mainly negative.
Several renal, prostate and endometrial cancers showed moderate membranous positivity. A few cases of liver and pancreatic cancers showed strong immunoreactivity. Remaining cancer tissues were in general negative.
GENE INFORMATION
Gene name
GGT1 (HGNC Symbol)
Synonyms
CD224, D22S672, D22S732, GGT
Description
Gamma-glutamyltransferase 1 (HGNC Symbol)
Entrez gene summary
The enzyme encoded by this gene is a type I gamma-glutamyltransferase that catalyzes the transfer of the glutamyl moiety of glutathione to a variety of amino acids and dipeptide acceptors. The enzyme is composed of a heavy chain and a light chain, which are derived from a single precursor protein. It is expressed in tissues involved in absorption and secretion and may contribute to the etiology of diabetes and other metabolic disorders. Multiple alternatively spliced variants have been identified. There are a number of related genes present on chromosomes 20 and 22, and putative pseudogenes for this gene on chromosomes 2, 13, and 22. [provided by RefSeq, Jan 2014]
Enzymes ENZYME proteins Transferases Hydrolases CD markers Predicted intracellular proteins Plasma proteins Candidate cardiovascular disease genes Disease related genes Potential drug targets Protein evidence (Ezkurdia et al 2014)
Enzymes ENZYME proteins Transferases Hydrolases CD markers Predicted intracellular proteins Plasma proteins Candidate cardiovascular disease genes Disease related genes Potential drug targets Protein evidence (Ezkurdia et al 2014)
Enzymes ENZYME proteins Transferases Hydrolases CD markers Predicted intracellular proteins Plasma proteins Candidate cardiovascular disease genes Disease related genes Potential drug targets Protein evidence (Ezkurdia et al 2014)